Matthias Ludwig - Search Results

Year	Number of Results
2006	1
2010	1
2011	1
2012	1
2014	2
2015	2
2020	1
2021	1
2024	0

1

First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.

Yap TA, Tan DSP, Terbuch A, Caldwell R, Guo C, Goh BC, Heong V, Haris NRM, Bashir S, Drew Y, Hong DS, Meric-Bernstam F, Wilkinson G, Hreiki J, Wengner AM, Bladt F, Schlicker A, Ludwig M, Zhou Y, Liu L, Bordia S, Plummer R, Lagkadinou E, de Bono JS. Yap TA, et al. Among authors: ludwig m. Cancer Discov. 2021 Jan;11(1):80-91. doi: 10.1158/2159-8290.CD-20-0868. Epub 2020 Sep 28. Cancer Discov. 2021. PMID: 32988960 Free PMC article.

2

Affinity of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives to the ion channel binding site of the NMDA receptor complex.

Ludwig M, Hoesl CE, Höfner G, Wanner KT. Ludwig M, et al. Eur J Med Chem. 2006 Aug;41(8):1003-10. doi: 10.1016/j.ejmech.2006.03.005. Epub 2006 May 3. Eur J Med Chem. 2006. PMID: 16675066

3

Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study.

Zurth C, Schuett B, Casjens M, Ludwig M, Waellnitz K. Zurth C, et al. Among authors: ludwig m. Clin Pharmacol Drug Dev. 2015 Jul;4(4):245-55. doi: 10.1002/cpdd.185. Epub 2015 May 8. Clin Pharmacol Drug Dev. 2015. PMID: 27136904 Clinical Trial.

4

Pharmacokinetic drug-drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate.

Winkler J, Goldammer M, Ludwig M, Rohde B, Zurth C. Winkler J, et al. Among authors: ludwig m. Eur J Drug Metab Pharmacokinet. 2015 Dec;40(4):389-99. doi: 10.1007/s13318-014-0215-8. Epub 2014 Jul 6. Eur J Drug Metab Pharmacokinet. 2015. PMID: 24997757 Clinical Trial.

5

Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study.

Höchel J, Schuett B, Ludwig M, Zurth C. Höchel J, et al. Among authors: ludwig m. Int J Clin Pharmacol Ther. 2014 Oct;52(10):856-66. doi: 10.5414/CP202085. Int J Clin Pharmacol Ther. 2014. PMID: 25138681 Clinical Trial.

6

Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.

Boettcher MF, Heinig R, Schmeck C, Kohlsdorfer C, Ludwig M, Schaefer A, Gelfert-Peukert S, Wensing G, Weber O. Boettcher MF, et al. Among authors: ludwig m. Br J Clin Pharmacol. 2012 Feb;73(2):210-8. doi: 10.1111/j.1365-2125.2011.04083.x. Br J Clin Pharmacol. 2012. PMID: 21838789 Free PMC article. Clinical Trial.

7

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors.

Brendel E, Ludwig M, Lathia C, Robert C, Ropert S, Soria JC, Armand JP. Brendel E, et al. Among authors: ludwig m. Cancer Chemother Pharmacol. 2011 Jul;68(1):53-61. doi: 10.1007/s00280-010-1423-9. Epub 2010 Sep 7. Cancer Chemother Pharmacol. 2011. PMID: 20821331 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year